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AbstrACt 
Objective Using meta-regression this paper sets out the 
minimum change in body mass index-SD score (BMI-SDS) 
required to improve adiposity as percentage body fat for 
children and adolescents with obesity.
Design Meta-regression.
setting Studies were identified as part of a large-scale 
systematic review of the following electronic databases: 
AMED, Embase, MEDLINE via OVID, Web of Science and 
CENTRAL via Cochrane library.
Participants Individuals aged 4–19 years with a 
diagnosis of obesity according to defined BMI thresholds.
Interventions Studies of lifestyle treatment interventions 
that included dietary, physical activity and/or behavioural 
components with the objective of reducing obesity were 
included. Interventions of <2 weeks duration and those 
that involved surgical and/or pharmacological components 
(eg, bariatric surgery, drug therapy) were excluded.
Primary and secondary outcome measures To be 
included in the review, studies had to report baseline and 
post-intervention BMI-SDS or change measurements 
(primary outcome measures) plus one or more of the 
following markers of metabolic health (secondary outcome 
measures): adiposity measures other than BMI; blood 
pressure; glucose; inflammation; insulin sensitivity/
resistance; lipid profile; liver function. This paper focuses 
on adiposity measures only. Further papers in this series 
will report on other outcome measures.
results This paper explores the potential impact of BMI-
SDS reduction in terms of change in percentage body fat. 
Thirty-nine studies reporting change in mean percentage 
body fat were analysed. Meta-regression demonstrated 
that reduction of at least 0.6 in mean BMI-SDS ensured a 
mean reduction of percentage body fat mass, in the sense 
that the associated 95% prediction interval for change in 
mean percentage body fat was wholly negative.
Conclusions Interventions demonstrating reductions of 0.6 
BMI-SDS might be termed successful in reducing adiposity, a 
key purpose of weight management interventions.
trial registration number CRD42016025317.
IntrODuCtIOn
Childhood obesity is one of the most serious 
global public health challenges of the 21st 
century.1 In England, the latest figures 
from the National Child Measurement 
Programme, which measures the height and 
weight of around 1 million school children 
every year, showed that 9.5% of children aged 
4–5 years and 20.1% of those aged 10–11 years 
were obese.2 3 Childhood obesity has adverse 
health consequences in both the short-term 
and long-term, including an increased risk 
of developing metabolic disturbances, like 
hypertension, dyslipidaemia and insulin 
resistance, and becoming obese adults.4 The 
presence of adverse changes in cardiac and 
vascular function and type 2 diabetes, which 
were previously considered adult morbidities, 
now being identified in children and adoles-
cents with obesity5–11 illustrates the urgent 
need for effective weight management treat-
ment interventions to reduce adiposity and 
improve the metabolic health status of the 
paediatric population.
Moderate weight loss has been shown to 
have a positive impact on many metabolic 
and cardiovascular risk factors.12 13 Weight 
management interventions for adults with 
strengths and limitations of this study
 ► We believe that this is the first paper to attempt to 
bring together all studies that have reported both a 
change in body mass index-SD score and changes 
in a marker of adiposity in the paediatric population 
with obesity.
 ► The systematic methods employed to identify the 
included studies were stringent, but it is possible 
that some relevant studies might have been missed.
 ► There was some variation in the reporting of results 
where there were multiple publications of the same 
study; in these cases, the results from the most 
comprehensive paper have been used.
 ► Studies that did not report change in mean per-
centage body fat could not be included in this 
meta-regression.
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obesity that result in a 5–10% decrease in body weight 
are associated with significant improvements in blood 
pressure, serum lipid levels and glucose tolerance14 
and reduction in the prevalence of hypertension and 
diabetes.15 Minimum weight management targets can 
therefore be set to improve metabolic health in this 
population.16
During childhood, all measurements over time are 
complicated by the influence of growth, meaning that 
cut-offs routinely used in the adult population cannot 
be used in children and adolescents. However, measured 
values of body mass index (BMI) can be standardised 
into SD scores (SDS) with respect to reference popula-
tions.17 These standardised scores, referred to as BMI-SDS 
throughout this paper, provide a normalised measure-
ment for the degree of obesity in children and young 
people, indicating to what degree an individual BMI lies 
above or below the median BMI value.
A meta-analysis by Ho et al18 concluded that lifestyle 
interventions can lead to improvements in weight and 
cardiometabolic outcomes in child obesity. However, 
while numerous lifestyle intervention programmes to 
tackle childhood obesity are conducted across the UK, 
and many describe statistically significant reductions in 
BMI-SDS,19 these results do not necessarily translate into 
clinical benefit for the individual. How reducing BMI-SDS 
in a trial translates to a reduction in adiposity is uncertain.
Paediatric weight management guidelines exist in many 
countries to promote best practice, but at present many 
of these recommendations are based on low-grade scien-
tific evidence.20 Understanding how much BMI must be 
reduced to positively affect body composition and meta-
bolic health is important to ensure that treatment inter-
ventions are appropriately designed and evaluated.21
Given the scale of the obesity problem and the signif-
icant and sustained adverse effects on health, clinically 
effective paediatric weight management treatment 
options are vital. A meta-analysis of cardiovascular disease 
risk in healthy children and its association with BMI has 
been conducted,22 but there is yet to be a systematic quan-
tification of the reduction in BMI required to improve 
adiposity in the paediatric population with obesity.
It is important to highlight that when assessing inter-
ventions designed to manage overweight and obesity 
in children and adolescents, it is essential to recognise 
that measures such as BMI and derived SDS are surro-
gates of the real purpose: reduction of adiposity, fat 
being the key organ involved in metabolic complica-
tions.23 To rigorously assess the clinical and cost-effec-
tiveness of weight management interventions in young 
people, it is first necessary to understand what BMI-SDS 
change means in terms of key outcomes such as effects on 
adiposity. This paper is designed to put BMI-SDS changes 
in context when considering improvement in adiposity 
(fatness). Through meta-regression analysis, we explore 
the potential impact of BMI-SDS reduction in terms of 
change in percentage body fat. The outcome of which 
will both inform clinical guidelines for paediatric weight 
management interventions and guide outcome measures 
in future clinical trials.
Objective
This paper aims to establish the minimum change in 
BMI-SDS needed to effect improvements in adiposity 
markers of children and adolescents with obesity. This is 
the first of a series of three papers reporting on the find-
ings from studies identified in a large systematic review 
(n=90 studies; searched up to May 2017) and focuses on 
the evidence in relation to adiposity (percentage body fat); 
the others relating to metabolic and cardiovascular health.
MethODs
The studies included in this paper were identified 
as part of large-scale systematic review (PROSPERO 
CRD42016025317). The protocol for this systematic 
review is available: https:// doi. org/ 10. 1186/ s13643- 016- 
0299- 0. The final search was conducted in May 2017, the 
review was completed in January 2018 and the results are 
still being evaluated.
Participants
Studies with participants aged 4–19 years with a diagnosis 
of obesity using defined BMI thresholds were considered 
for inclusion. BMI-SDS was calculated as a function of the 
degree of obesity of the subjects when compared with BMI 
references. BMI standards included, but were not limited 
to, the 98th percentile on the UK 1990 growth reference 
chart,24 95th percentile on the US Centre for Disease 
Control and Prevention growth chart,25 the International 
Obesity Task Force (IOTF) BMI for age cut-points26 and 
the WHO growth references,27 28 in addition to coun-
try-specific obesity thresholds using BMI reference data 
from their paediatric populations. Studies that included 
overweight, as opposed to obese, individuals, pregnant 
females or those with a critical illness, endocrine disor-
ders or syndromic obesity were excluded from this review.
Interventions
Studies of lifestyle treatment interventions that included 
dietary, physical activity and/or behavioural components 
with the objective of reducing obesity were included. 
Interventions of <2 weeks duration and those that 
involved surgical and/or pharmacological components 
(eg, bariatric surgery, drug therapy) were excluded. 
Studies focused on obesity prevention were also excluded. 
No restrictions were imposed regarding the setting or 
delivery of the interventions.
Outcome measures
To meet the inclusion criteria of the full systematic review, 
interventions had to report baseline (preintervention) 
and postintervention BMI-SDS or change measurements 
of BMI-SDS plus one or more markers of metabolic 
health (please refer to the published protocol paper for a 
complete list of the metabolic health markers of interest; 
https:// doi. org/ 10. 1186/ s13643- 016- 0299- 0).
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This paper focuses on change in BMI-SDS and adiposity 
measures other than BMI, including waist circumference 
and percentage body fat.
study design
Completed, published, randomised controlled trials 
(RCTs) and non-randomised studies (cohort studies) of 
lifestyle treatment interventions for children and adoles-
cents with obesity, with or without follow-up.
ethics
Ethical approval was not required as this paper reviewed 
published studies only.
Patient and public involvement
There was no patient or public involvement in this review 
of published studies.
Information sources and search methods
Studies were identified by searching five electronic data-
bases from inception to May 2017 (AMED, Embase, 
MEDLINE via OVID, Web of Science and CENTRAL via 
Cochrane library), alongside scanning reference lists of 
included articles and through consultation with experts 
in the field. The search strategy for MEDLINE database is 
presented in online supplementary appendix 1.
study selection and data extraction
Titles and abstracts were assessed for eligibility and 
the data outcome measures described previously were 
extracted by two independent reviewers from the review 
team using a standardised data extraction template, 
which was piloted by both reviewers before starting the 
review to ensure consistency.
Quality assessment
The focus of this study is the relationship between change 
in BMI-SDS and change in metabolic health parameters, 
rather than the specific treatment interventions that effect 
those changes. Therefore, risk of bias tools, such as the 
Cochrane Risk of Bias tool,29 were not considered appro-
priate. The included studies were assessed for methodolog-
ical quality by two members of the review team during the 
data extraction process using the Quality Assessment tool 
used in the 2004 Health Technology Assessment (HTA) 
systematic review of the long-term effects and economic 
consequences of treatments for obesity and implications 
for health improvement.30 This Quality Assessment tool 
comprises 20 questions which are added together to give 
a final score and a percentage rating, from which a level 
of quality is assigned. Any discrepancies in Quality Assess-
ment scoring were resolved through discussion.
Analysis
We carried out random-effects meta-regression as 
implemented in Stata31 to try to quantify the relation-
ship between mean change in BMI-SDS (independent, 
predictor variable) and mean change in percentage body 
fat (target variable), where these were either reported, or 
were able to be calculated from reported data. Further 
details are given below. We were not trying to assess the 
relative effects of the various interventions, but rather to 
examine the relationship between these two outcomes. 
Meta-regression allows for residual heterogeneity in the 
target variable not explained by the predictor. Subsets 
from the same study (eg, intervention vs control, boys vs 
girls, see below) were regarded as independent observa-
tions provided there was no data duplication.
results
search results
In total, 98 published articles relating to 90 different 
studies met the inclusion criteria for the entire system-
atic review. See figure 1 for a flow diagram illustrating the 
number of papers excluded at each stage of the review. 
For studies reported in multiple publications, the refer-
ence that provided the most comprehensive information 
has been used (see footnote of table 1 for details).
The Venn diagram (figure 2) illustrates how many 
studies were identified for the various markers of meta-
bolic health. Seventy-three studies assessed and reported 
adiposity measures. The adiposity measures reported 
included percentage body fat, body fat-SDS, body mass, fat 
mass, fat-free mass, waist circumference and waist circum-
ference-SDS. The 68 studies that examined diabetes/
inflammation measures (HOMA-IR, insulin, glucose, C 
reactive protein, interleukin-6, alanine transaminase and 
the 71 studies examining cardiac measures (eg, lipids, 
cholesterol, blood pressure) will be reported separately.
studies for inclusion in meta-regression analysis
Seventy-three studies assessed and reported adiposity 
measures. Of the different adiposity measures that were 
reported in these studies (percentage body fat, body 
fat-SDS, body mass, fat mass, fat-free mass, waist circum-
ference and waist circumference-SDS), we elected to 
examine percentage body fat as it was far more frequently 
reported across studies. Therefore, of the 73 adiposity 
studies, we conducted our meta-regression on 39 studies 
which reported percentage body fat values. These studies 
are presented in table 1 with the corresponding changes 
in BMI-SDS.
The results of five studies were duplicated in multiple 
papers, thus the reference that reported the most 
comprehensive information was used in the analysis; 
see table 1 footnote for details. Thirty-four studies were 
excluded from the meta-analysis; the characteristics of 
the excluded studies, along with the reason for exclusion, 
are summarised in online supplementary appendix 2.
narrative description of studies that reported bMI-sDs and 
percentage body fat
Of the 39 studies that reported percentage body fat 
included in our analysis, 7 were conducted in both 
Germany and the USA, 4 in Italy, followed by Australia 
(n=2), Denmark (n=2), the Netherlands (n=2), Poland 
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(n=2), Switzerland (n=2), Tunisia (n=2) and one each 
in Belgium, Brazil, Canada, Chile, France, Portugal, 
Spain, Thailand and the UK. There were country-specific 
variations in the definition of obesity, with most studies 
defining obesity by participants having a BMI-SDS >2, 
or a BMI percentile of at least >90th percentile. Most of 
studies used a cohort design (n=27), 11 were RCTs, of 
which 1 included results from a cohort of the original 
RCT. There was also one study which adopted a quasi-ran-
domised design.
Most studies (n=20) conducted their intervention in 
the hospital clinic setting. Eight studies conducted the 
intervention in the community setting and 10 in academic 
institutions. One conducted the intervention in a mixed 
setting, reporting use of both a community setting and 
academic institution.
Twenty-eight studies conducted interventions that 
comprised both diet and exercise components. The 
remaining studies (n=11) used interventions that 
focused either on exercise or diet only. The duration 
of the interventions ranged from 15 days to 24 months. 
The majority of studies (n=29; 74%) did not report 
any follow-up after the lifestyle treatment intervention. 
The duration of follow-up in the studies where it was 
conducted and reported, ranged from 6 months to 2 
years.
The sample sizes of the included studies ranged from 
8 to 203 participants. The age of the participants ranged 
from 4 to 19 years. Studies predominantly had a mix of 
males and females (95%) with only three studies specif-
ically focused on either only girls32 33 or boys.34 Seven-
teen studies (44%) measured pubertal development of 
participants according to Marshall and Tanner staging, 
with pubertal status categorised into three groups: 
prepubertal, pubertal and late/postpubertal.35 Four 
studies (10%) reported that pubertal development was 
measured but the methodology was not defined. Eighteen 
studies (46%) did not report any measures of pubertal 
development.
Figure 1 Flow diagram from the systematic review that identified the included studies. BMI-SDS: body mass index-SD 
score; HOMA, homeostatic model assessment (method of assessing insulin resistance); OB: obese; OW: overweight. 
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Quality assessment
The quality of the conduct of each study was assessed 
using the same criteria as the HTA systematic review 
of the long-term effects and economic consequences 
of treatments for obesity and implications for health 
improvement.30 The results of the quality assessment can 
be found in table 2. In summary, none of the 39 studies 
that reported percentage body fat were considered to be 
of poor quality, 21 studies (54%) were rated as being of 
moderate quality and 18 studies (46%) achieved a score 
over 81% indicating high quality.
Quantitative analysis
From the 39 studies we identified all data subsets that 
reported a mean change in BMI-SDS, an associated mean 
change in percentage body fat (or prestudy and post-
study values from which these could be calculated) and 
the number of cases analysed. A few studies yielded only 
aggregated data for the whole study. For the others, typical 
data subsets included intervention versus control, male 
versus female or good versus poor responders (table 1), 
and these were used in preference to aggregated results 
if both were available. In all, there were 66 subsets, with 
numbers analysed totalling 2618.
SEs were required for the mean changes in percentage 
body fat and, if not given explicitly, were calculated, from 
either the SDs or the 95% CIs of the mean changes. In 
total, 22 data sets had SEs. For the remainder, the SEs 
were estimated from the SDs associated with the base-
line and the postintervention percentage body fat values, 
making an assumption about the degree of correlation 
between them. The median and IQR of the correlation 
coefficients estimated from the nine data sets where both 
the SEs of mean change and the SDs for baseline and 
postintervention percentage body fat values were avail-
able was 0.81 (IQR 0.59–0.82) and 0.81 has been used in 
the following analysis.
A small number of data sets (n=6)36–38 only had 
medians and IQRs (or range) reported for the baseline 
and postintervention results; the mean and SDs were esti-
mated from them.39
The meta-regression line was fitted and plotted 
together with the 95% prediction intervals for the change 
in percentage body fat across the study data sets. The 
smallest reduction of mean BMI-SDS associated with a 
reduction in mean percentage body fat was determined 
as the smallest reduction in mean BMI-SDS with an asso-
ciated 95% prediction interval wholly below zero.
A series of sensitivity analyses were conducted. Sensi-
tivity analysis 5A: using the 22 cases where the SEs of the 
mean change in percentage body fat were actually known, 
sensitivity analysis 5B: omission of two extreme values 
and sensitivity analysis 5C: assuming a correlation of 
0.50 instead of 0.81. In further exploratory analyses, the 
percentage of girls and the length of the study (baseline 
to end of intervention) were added to see if these affected 
the prediction of mean change in percentage body fat.
results from the quantitative analysis
Figure 3 shows the results of the analysis and the fitted 
regression line. The circles represent the study results 
(ie, the mean changes in percentage body fat and mean 
changes in BMI-SDS) analysed for each study, with the 
size of the circles representing the precision of the mean 
change in percentage body fat, that is, the reciprocal of 
the SE squared.
The fitted regression line shown in figure 3 is:
Mean change in percentage body fat=5.179×mean 
change in BMI-SDS−0.767.
The regression slope was statistically significant 
(p<0.001), confirming a relationship between the mean 
loss of percentage body fat and the mean change in 
BMI-SDS across the data subsets; the proportion of the 
between-subset variance explained by the mean change 
in BMI-SDS (ie, ‘a type of adjusted R-squared’) was 68%. 
There was, however, significant between-subset heteroge-
neity with 89% of the percentage of the total residual vari-
ance attributable to this (ie, I2).2 It was further noted that 
when added to the model, neither the percentage girls 
in the study sets nor the durations of the interventions 
significantly improved the prediction of mean change in 
percentage body fat from the mean change in BMI-SDS 
(p=0.36, p=0.89, respectively).
Figure 3 also shows the 95% prediction intervals for the 
mean change in percentage body fat. The upper limit of 
the prediction interval was below 0 only when the mean 
reduction in BMI-SDS was >0.6, suggesting that any new 
study should aim to reduce the BMI-SDS by at least this 
amount to be confident of achieving a mean reduction of 
percentage body fat.
A normal plot for the standardised predicted random 
effects is shown in figure 4. Most were within ±2, although 
the data sets themselves were not wholly independent (as 
some came from the same studies).
None of the sensitivity analyses conducted (figure 5) 
significantly altered the findings, namely that a mean 
change of 0.6 or more in BMI-SDS was associated with a 
Figure 2 Venn diagram illustrating the markers of metabolic 
health measured.
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definitive mean loss in percentage body fat. In figure 5B, 
with the exclusion of the two extreme data points, the 
linear trend can be seen more clearly across the range of 
mean BMI-SDS losses.
DIsCussIOn
summary of main results
This is the first of a series of papers that report on studies 
identified in a large systematic review. The objective of this 
paper was to attempt to establish the minimum change 
in BMI-SDS needed to achieve improvements in body fat 
in children and adolescents with obesity; BMI-SDS being 
by far the most frequently reported outcome in terms 
of weight management trial interventions in childhood. 
Seventy-three of the 90 included studies reported adiposity 
measures, but in our meta-regression only percentage 
body fat can be used as a reliable, comparable marker of 
change of adiposity. Thus, the analyses presented in this 
paper were conducted using data from 39 studies. All of 
the included studies were considered to be of moderate 
to high quality according to the HTA quality assessment 
tool.30 Despite there being a positive relationship between 
mean change in percentage body fat and mean change in 
BMI-SDS, our modelling suggested that, in order to be 
confident of effecting a mean loss in percentage body fat, 
any future study should aim to reduce the BMI-SDS by at 
least 0.6.
strengths and limitations
We believe that this is the first paper to attempt to bring 
together all studies that have reported both a change 
in BMI-SDS and changes in a marker of adiposity in 
the paediatric population with obesity. The systematic 
methods employed to identify the included studies were 
stringent, but it is possible that some relevant studies 
might have been missed. In addition, there was some 
variation in the reporting of results where there were 
multiple publications of the same study; in these cases, 
the results from the most comprehensive paper have been 
used. An important limitation to address in the broader 
context going forward is whether BMI-SDS is the best way 
to represent changes in BMI at extremes of body weight. 
The US Center for Disease Control cautioned the use of 
BMI-SDS in weight extremes in 2009.40 Freedman et al 
have suggested that there are better measures of adiposity 
in severe obesity, such as percentage of 95th percentile 
BMI (%BMIp95) or distance in kg/m2 from the 95th 
Figure 3 Meta-regression line showing the relationship 
between mean change in percentage body fat and body 
mass index-SD score (BMI-SDS) across the 39 studies (66 
subsets) analysed.
Figure 4 Normal plot for the standardised predicted random 
effects from the meta-regression.
Figure 5 Sensitivity analysis. BMI-SDS, body mass index- 
SD score. (A) Analyses based on the 22 subsets where the 
SEs of the mean changes in percentage Body Fat were 
known (Fitted meta-regression line: Mean change in % body 
fat = 4.502 x Mean change in BMI-SDS – 0.810). (B) Analysis 
using all data subsets but excluding two extreme values 
(reduction of mean BMI-SDS of more than 1.5), leaving 64 
subsets (Fitted meta-regression line: Mean change in % body 
fat = 7.078 x Mean change in BMI-SDS – 0.318). (C) Analysis 
using all 66 data subsets but using a correlation coefficient of 
0.50, rather than 0.81, to estimate the SE of the mean change 
in % Body Fat for the 66–22=44 subsets where this was not 
available (Fitted regression line: Mean change in % body fat = 
5.039 x Mean change in BMI-SDS - 0.783). 
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percentile (ΔBMIp95).41 Other groups have identified 
alternate methods when dealing with extremes of obesity 
such as BMI%42 or percentage above IOTF-25.43 Vander-
well et al have also suggested that BMI-SDS is only a weak 
to moderate predictor of percentage body fat in children, 
especially under 9 years of age.44 Notwithstanding these 
cautions, we based this analysis on the data available to us 
which was almost entirely reported in terms of BMI-SDS 
and continues to be the case in most recent publications 
to date.
It has been suggested that the relationship between 
change in percentage body fat and change in BMI-SDS 
may differ between very young and older children.45 Our 
inclusion criteria stipulated ages from 4 to 19 years. Most 
of the studies spanned a wide range of ages (table 1) and 
we did not have access to individual child data to facilitate 
stratification by age. Data from four subsets of children 
up to 10 years,37 46 47 however, did not suggest a different 
relationship from the whole cohort (see online supple-
mentary appendix 3).
Agreements and disagreements with other research
Previous research has shown that an improvement in body 
composition and cardiometabolic risk can be achieved 
with a BMI-SDS reduction of ≥0.25 in adolescents with 
obesity, with greater benefits achieved when losing at least 
0.5 BMI-SDS.48
In clinical practice, the degree of weight loss with life-
style intervention is moderate and the success rate 2 years 
after onset of an intervention is low (<20% with a decrease 
in BMI-SDS <0.25).49 There have been numerous reports 
of lifestyle-based weight management interventions for 
children with obesity, many documenting changes in 
BMI-SDS, but a recent meta-analysis has documented that 
while such changes may be statistically significant, they 
are unlikely to lead to clinical improvements in metabolic 
health.50 51 To our knowledge, this is the first paper to 
establish the minimum change in BMI-SDS required to 
be certain of improving adiposity as percentage body fat 
for children and adolescents with obesity in clinical trials.
Clinical implications
If reducing fat mass is the aim of weight management 
interventions, our analysis in this review demonstrates 
that BMI-SDS changes must be of an order seldom 
achieved in trials worldwide. From our model, to be confi-
dent about ensuring an improvement in mean body fat, 
one should aim to reduce mean BMI-SDS by at least 0.6. 
Figure 3 and sensitivity analysis 5B (figure 5) suggest that 
to reduce body fat by 5% requires a much larger BMI-SDS 
reduction, of the order of 1.3–1.5, although there was a 
paucity of data in this region.
recommendations for future research
While we are undertaking further analyses looking at key 
cardiovascular and metabolic outcomes in childhood 
obesity that may demonstrate improvements at lesser 
levels of BMI-SDS reduction, the evidence suggests that 
very few childhood weight management trials to date are 
likely to have improved percentage body fat and calls in to 
question their overall efficacy in terms of health improve-
ment. That said, any trial demonstrating an improve-
ment of the magnitude of 0.6 BMI-SDS might be termed 
successful with a likely reduction in fat mass. However, 
given the mounting evidence that BMI-SDS may not accu-
rately reflect adiposity at extremes of obesity, it seems 
prudent for future trials to report additional indices of 
derived BMI values which may better reflect changes in 
actual adiposity. Which of the many measures suggested 
eventually establishes itself as the ‘optimal’ determinant 
at extremes of body mass is yet to be determined?
COnClusIOns
Using our model, to predict any fat mass improvement 
when reporting a weight management trial outcome 
requires a BMI-SDS decrease of 0.6. When evaluating 
key outcomes for future weight management trials 
and services, this figure needs to be borne in mind by 
researchers, healthcare professionals and commissioners 
when assessing apparent success.
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